The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
Professor Kevin Harrington | The Royal Marsden
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
The ICR on Twitter: "Professor Kevin Harrington introduces our world-leading work on #immunotherapy, and how we are finding new ways to tackle melanomas, head and neck, and other cancers #partneringtodefeatcancer https://t.co/Q2nRhOW9c7" /
World-first for viral therapy for cancer on Vimeo
Targeted Physical Therapies | TRM CancerBRC
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program
Professor Kevin Harrington - YouTube
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Scientific Lecture | Kevin Harrington | FRONTAL
Professor Kevin Harrington - The Institute of Cancer Research, London
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London
.jpg?sfvrsn=a729a68_4 "Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London")
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment?
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Richard Lofgren Interview...Episode 72 of the Invention Stories Podcast
The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of
